Detalles de la búsqueda
1.
Novel immune-related signature for risk stratification and prognosis in prostatic adenocarcinoma.
Cancer Sci
; 112(10): 4365-4376, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-34252262
2.
ARNT-dependent CCR8 reprogrammed LDH isoform expression correlates with poor clinical outcomes of prostate cancer.
Mol Carcinog
; 59(8): 897-907, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32319143
3.
Correction to: MicroRNA-30d promotes angiogenesis and tumor growth via MYPT1/c-JUN/VEGFA pathway and predicts aggressive outcome in prostate cancer.
Mol Cancer
; 18(1): 122, 2019 Aug 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31387585
4.
Expression of PD-L1 in tumor-associated nerves correlates with reduced CD8+ tumor-associated lymphocytes and poor prognosis in prostate cancer.
Int J Cancer
; 144(12): 3099-3110, 2019 06 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-30537104
5.
Downregulation of ARID4A and ARID4B promote tumor progression and directly regulated by microRNA-30d in patient with prostate cancer.
J Cell Biochem
; 119(9): 7245-7255, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29797600
6.
Retraction Note: MicroRNA-30d promotes angiogenesis and tumor growth via MYPT1/c-JUN/VEGFA pathway and predicts aggressive outcome in prostate cancer.
Mol Cancer
; 22(1): 56, 2023 Mar 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-36941584
7.
MicroRNA-30d promotes angiogenesis and tumor growth via MYPT1/c-JUN/VEGFA pathway and predicts aggressive outcome in prostate cancer.
Mol Cancer
; 16(1): 48, 2017 02 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-28241827
8.
Decreased expression of TCF12 contributes to progression and predicts biochemical recurrence in patients with prostate cancer.
Tumour Biol
; 39(6): 1010428317703924, 2017 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-28651494
9.
MicroRNA-224 and its target CAMKK2 synergistically influence tumor progression and patient prognosis in prostate cancer.
Tumour Biol
; 36(3): 1983-91, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-25394900
10.
Overexpression of NIMA-related kinase 2 is associated with progression and poor prognosis of prostate cancer.
BMC Urol
; 15: 90, 2015 Aug 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-26320076
11.
MicroRNA-224 inhibits progression of human prostate cancer by downregulating TRIB1.
Int J Cancer
; 135(3): 541-50, 2014 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-24382668
12.
MicroRNA-30c serves as an independent biochemical recurrence predictor and potential tumor suppressor for prostate cancer.
Mol Biol Rep
; 41(5): 2779-88, 2014 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-24452717
13.
Global analysis of the differentially expressed miRNAs of prostate cancer in Chinese patients.
BMC Genomics
; 14: 757, 2013 Nov 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-24191917
14.
Expression of SOCSs in human prostate cancer and their association in prognosis.
Mol Cell Biochem
; 381(1-2): 51-9, 2013 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-23666742
15.
Down-regulation of the ErbB3 binding protein 1 in human bladder cancer promotes tumor progression and cell proliferation.
Mol Biol Rep
; 40(5): 3799-805, 2013 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-23283744
16.
Expression of CD147 is associated with prostate cancer progression.
Int J Cancer
; 130(2): 300-8, 2012 Jan 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-21328337
17.
SOXs in human prostate cancer: implication as progression and prognosis factors.
BMC Cancer
; 12: 248, 2012 Jun 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-22703285
18.
[Case-control study on the correlation of bladder cancer incidence and occupational factors].
Zhonghua Yi Xue Za Zhi
; 92(28): 1978-80, 2012 Jul 24.
Artículo
en Zh
| MEDLINE | ID: mdl-22944273
19.
[Effects of PPAR-gamma on the proliferation and glycolysis metabolism of prostate cancer cells].
Zhonghua Nan Ke Xue
; 18(8): 692-6, 2012 Aug.
Artículo
en Zh
| MEDLINE | ID: mdl-22934513
20.
Mannose inhibits the growth of prostate cancer through a mitochondrial mechanism.
Asian J Androl
; 24(5): 540-548, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35142655